<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3316">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04368637</url>
  </required_header>
  <id_info>
    <org_study_id>JCCG.JoCORE.4.4040</org_study_id>
    <nct_id>NCT04368637</nct_id>
  </id_info>
  <brief_title>Acute Cardiovascular Events Triggered by COVID-19-Related Stress</brief_title>
  <acronym>JoCORE</acronym>
  <official_title>Acute Cardiovascular Events Triggered by COVID-19-Related, Non-infectious Stress The Jordan COVID-9 caRdiovascular Events (JoCORE) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jordan Collaborating Cardiology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jordan Collaborating Cardiology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current COVID19 pandemic has afflicted almost the whole globe. The stress related to the&#xD;
      pandemic, not the direct virus-related injury, can be potentially associated with acute&#xD;
      cardiovascular events due to a large list of physical and psychosocial stresses.&#xD;
&#xD;
      This study is a cross sectional study that will enroll patients evaluated during the COVID19&#xD;
      pandemic period for acute cardiovascular events.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The onset of acute myocardial infarction (AMI) is a complex interplay of internal circadian&#xD;
      factors and external physical and emotional triggers. These interactions may lead to rupture&#xD;
      of an often non-occlusive vulnerable atherosclerotic coronary plaque with subsequent&#xD;
      formation of an occlusive thrombus. Physical and emotional stresses are important triggers of&#xD;
      acute cardiovascular events including AMI. Triggering events, internal changes, and external&#xD;
      factors vary among different geographical, environmental, and ethnic regions. Life-style&#xD;
      changes, pharmacotherapy, and psychological interventions may potentially modify the response&#xD;
      to, and protect against the effects of triggering events. Certain times in the life span of&#xD;
      different communities all around the world are prone to natural and man-made disasters that,&#xD;
      not only have direct negative impact on human lives and state-resources, but also have&#xD;
      indirect impact on triggering acute cardiovascular events during the time of the disaster and&#xD;
      the period immediately after. For example, earthquakes, wars, and terrorist attacks, in&#xD;
      addition to direct human life loss and destruction of communities, have bees associated with&#xD;
      a surge in the number of acute MI, sudden cardiac death, ventricular tachy-arrhythmia and&#xD;
      implantable cardiovertor defibrillators (ICD) discharges.&#xD;
&#xD;
      The current COVID-19 pandemic has afflicted almost the whole globe. The virus can directly&#xD;
      attack the myocyte and cause various degrees of cardiac damage and cardiovascular clinical&#xD;
      entities. However, the stress related to the pandemic, not the direct virus-related injury,&#xD;
      can be potentially associated with acute cardiovascular events due to a large list of&#xD;
      physical and psycho-social stresses such as extreme physical effort, lock down, anger, fear,&#xD;
      financial stress, sorrow, death of a significant person..etc.&#xD;
&#xD;
      This study is a cross sectional study that will enroll patients evaluated during the COVID-19&#xD;
      pandemic period for acute cardiovascular events not directory related to the virus&#xD;
      infectivity, who voice certain and specific trigger(s) related to the pandemic impact on&#xD;
      social life and physical activity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2020</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute cardiovascular event triggered by COVID-19 stress</measure>
    <time_frame>4 months</time_frame>
    <description>Acute myocardial infarction as diagnosed by ST segment elevation or depression or inverted T wave on 12-lead EKG and elevated levels of cardiac troponins above the 99% of the normal values.&#xD;
A. Acute MI (STEMI and NSTEMI). B. Aborted on non-aborted sudden cardiac death not attributed to a known etiology.&#xD;
C. Sustained or non-sustained ventricular tachy-arrhythmia not attributed to a known etiology.&#xD;
D. ICD shocks. 3. Absence of suspected or confirmed infection with the COVID19 virus. 4. Definite physical or psycho-social stressful trigger appearing in relation to the COVID-19 situation (lock down stress, financial stress, anger, depression, fear, sorrow, death of a significant person, eating binges, smoking binges, physical stress [carrying walking for shopping and carrying excess weights] ..etc) as judged by a unanimous agreement of three investigators in the steering committee.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventricular tachycardia</measure>
    <time_frame>4 months</time_frame>
    <description>Typical ventricular tachycardia on 12-lead EKG or EKG monitor.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>acute stroke</measure>
    <time_frame>4 months</time_frame>
    <description>acute neurological symptoms of hemiparesis or dysrthria due to brain ischemia proven by computerized tomography or magnatic resonance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implantable cardioverter defibrillator (ICD) shock</measure>
    <time_frame>4 months</time_frame>
    <description>Finding an episode of ventricular tachycardia on interrogation of ICD tracing</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Sudden Cardiac Death</condition>
  <condition>Stroke, Acute</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All comers to the ER reporting acute cardiovascular event as pre-specified above. The&#xD;
        patient reporting a physical or social stress directly related to the COVID-19 pandemic&#xD;
        such as anger, fear, death of a significant person, financial stress, eating binge, extreme&#xD;
        physical effort, etc..&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years.&#xD;
&#xD;
          -  Acute MI (STEMI and NSTEMI).&#xD;
&#xD;
          -  Sudden cardiac death&#xD;
&#xD;
          -  Ventricular tachycardia&#xD;
&#xD;
          -  ICD shocks.&#xD;
&#xD;
          -  Stressful trigger prior to the cardiovascular event&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        * COVID-19 infection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ayman J Hammoudeh, MD, FACC</last_name>
    <role>Study Chair</role>
    <affiliation>JCC Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ayman J Hammoudeh, MD, FACC</last_name>
    <phone>0096265001000</phone>
    <email>hammoudeh_ayman@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ayadeh Madanat, MD</last_name>
    <phone>00962796224241</phone>
    <email>ayadeh.madanat@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istishari Hospital</name>
      <address>
        <city>Amman</city>
        <zip>11184</zip>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayman Hammoudeh, MD, FACC</last_name>
      <phone>0096265001000</phone>
      <email>a.hammoudeh@istisharihospital.com</email>
    </contact>
    <contact_backup>
      <last_name>Walaa Abu Moghli, PharmD</last_name>
      <phone>0096265001000</phone>
      <email>a.hammoudeh@istisharihospital.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Abdelhadi Hospital</name>
      <address>
        <city>Amman</city>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zeina Abu Orabi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Zeina Abu Orabi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Farah Hospital</name>
      <address>
        <city>Amman</city>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadi Abu hantash, MD, FACC</last_name>
    </contact>
    <investigator>
      <last_name>Hadi Abu Hantash, MD, FACC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eyadeh Madanat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zaid Khouri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jordan Hospital</name>
      <address>
        <city>Amman</city>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Imad Alhaddad, MD</last_name>
      <phone>00962795303502</phone>
      <email>alhaddad63@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mahmoud Fakhri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Specialty Hospital</name>
      <address>
        <city>Amman</city>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud Izraiq Mahmoud Izraiq, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 26, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2020</study_first_posted>
  <last_update_submitted>May 4, 2020</last_update_submitted>
  <last_update_submitted_qc>May 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jordan Collaborating Cardiology Group</investigator_affiliation>
    <investigator_full_name>Ayman J. Hammoudeh, MD, FACC</investigator_full_name>
    <investigator_title>Interventional Cardiologist</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>triggered myocardial infarction</keyword>
  <keyword>triggered acute cardiovascular events</keyword>
  <keyword>COVID-19-related stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Death</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Baseline clinical data of participating patients will be shared along with the type of the triggered cardiovascular events and the type of trigger implicated in precipitating the event.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

